[HTML][HTML] Improvement in the pharmacological profile of copper biological active complexes by their incorporation into organic or inorganic matrix
Every year, more Cu (II) complexes are proven to be biologically active species, but very few
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix.
M Badea, V Uivarosi, R Olar - Molecules (Basel, Switzerland), 2020 - europepmc.org
Every year, more Cu (II) complexes are proven to be biologically active species, but very few
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
[PDF][PDF] Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix
M Badea, V Uivarosi, R Olar - Molecules, 2020 - researchgate.net
Every year, more Cu (II) complexes are proven to be biologically active species, but very few
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix.
M Badea, V Uivarosi, R Olar, M Ravera - Molecules, 2020 - search.ebscohost.com
Every year, more Cu (II) complexes are proven to be biologically active species, but very few
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
[HTML][HTML] Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix
M Badea, V Uivarosi, R Olar - Molecules, 2020 - ncbi.nlm.nih.gov
Every year, more Cu (II) complexes are proven to be biologically active species, but very few
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix
M Badea, V Uivarosi, R Olar - Molecules (Basel …, 2020 - pubmed.ncbi.nlm.nih.gov
Every year, more Cu (II) complexes are proven to be biologically active species, but very few
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix
M Badea, V Uivarosi, R Olar - Molecules, 2020 - search.proquest.com
Every year, more Cu (II) complexes are proven to be biologically active species, but very few
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
[PDF][PDF] Improvement in the Pharmacological Profile of Copper Biological Active Complexes by Their Incorporation into Organic or Inorganic Matrix
M Badea, V Uivarosi, R Olar - Molecules, 2020 - pdfs.semanticscholar.org
Every year, more Cu (II) complexes are proven to be biologically active species, but very few
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …
are developed as drugs or entered in clinical trials. This is due to their poor water solubility …